 |
Video: What is a Stock Split?
|
 |
Angion Biomedica is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapeutics to address chronic and progressive fibrotic diseases. Co.'s product candidates and programs include ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, a ROCK2 preclinical program targeted towards the treatment of fibrotic diseases, a CYP11B2 preclinical program targeted towards diseases related to aldosterone synthase dysregulation, and a CYP26 (retinoic acid metabolism) inhibitor program targeted towards a number of indications, including cancer, and ANG-3777, a hepatocyte growth factor mimetic. According to our ANGN split history records, ANGN has had 1 split. | |
 |

ANGN (ANGN) has 1 split in our ANGN split history database. The split for ANGN took place on May 18, 1999. This was a 1 for 10
reverse split, meaning for each 10
shares of ANGN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as ANGN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ANGN split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ANGN shares, starting with a $10,000 purchase of ANGN, presented on a split-history-adjusted basis factoring in the complete ANGN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/08/2021 |
|
End date: |
06/01/2023 |
|
Start price/share: |
$18.25 |
|
End price/share: |
$1.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.52% |
|
Average Annual Total Return: |
-71.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$548.14 |
|
Years: |
2.31 |
|
|
 |
Date |
Ratio |
05/18/1999 | 1 for 10
|
|
 |